Asset Allocation

As of November 30, 2025.
Type % Net
Cash 2.66%
Stock 59.42%
Bond 31.75%
Convertible 0.00%
Preferred 4.49%
Other 1.69%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 80.59%
Mid 16.17%
Small 3.23%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.27%    % Emerging Markets: 0.23%    % Unidentified Markets: 0.50%

Americas 98.87%
97.14%
Canada 90.93%
United States 6.21%
1.73%
Chile 0.03%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 0.56%
United Kingdom 0.45%
0.11%
Denmark 0.00%
France 0.02%
Germany 0.05%
Greece 0.00%
Ireland 0.00%
Italy 0.00%
Netherlands 0.03%
Spain 0.00%
0.00%
0.00%
Greater Asia 0.06%
Japan 0.03%
0.00%
Australia 0.00%
0.04%
Singapore 0.04%
0.00%
Unidentified Region 0.50%

Bond Credit Quality Exposure

AAA 20.76%
AA 13.09%
A 16.05%
BBB 21.84%
BB 11.97%
B 5.04%
Below B 0.29%
    CCC 0.29%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.05%
Not Available 10.91%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
41.35%
Materials
1.32%
Consumer Discretionary
3.85%
Financials
32.75%
Real Estate
3.43%
Sensitive
34.80%
Communication Services
1.66%
Energy
16.50%
Industrials
14.23%
Information Technology
2.41%
Defensive
9.74%
Consumer Staples
5.13%
Health Care
0.00%
Utilities
4.61%
Not Classified
14.11%
Non Classified Equity
1.66%
Not Classified - Non Equity
12.46%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 20.12%
Corporate 51.30%
Securitized 0.01%
Municipal 22.36%
Other 6.21%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
6.62%
Less than 1 Year
6.62%
Intermediate
57.36%
1 to 3 Years
8.87%
3 to 5 Years
19.24%
5 to 10 Years
29.25%
Long Term
33.84%
10 to 20 Years
8.77%
20 to 30 Years
13.27%
Over 30 Years
11.80%
Other
2.18%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial